Literature DB >> 22829587

Phosphoregulation of the RNA-binding protein Hu antigen R (HuR) by Cdk5 affects centrosome function.

Natalia Filippova1, Xiuhua Yang, Peter King, L Burt Nabors.   

Abstract

Hu antigen R (HuR) is an mRNA-binding protein belonging to the ELAV family. It is highly expressed in cancer and involved in cell survival and proliferation. The impact of post-translational regulation of HuR and resulting cellular effects are poorly understood. In the current report, we describe a direct interaction between HuR and Cdk5 in glioma. We determined that Cdk5 specifically phosphorylates HuR at the serine 202 residue in the unique hinge region. The molecular consequences of this interaction are an altered HuR ability to bind, stabilize, and promote translation of mRNAs. At the cellular level, the anomalous HuR phosphorylation at this site evokes robust defects in centrosome duplication and cohesion as well as arrest of cell cycle progression. Subcellular fractionation and immunofluorescence technique confirm a direct integration of HuR and Cdk5 with centrosomes. We propose that HuR stores mRNA in the centrosome and that HuR phosphorylation by Cdk5 controls de novo protein synthesis in near proximity to centrosomes and, thus, impacts centrosome function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22829587      PMCID: PMC3442558          DOI: 10.1074/jbc.M112.353912

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

Review 1.  HuR and mRNA stability.

Authors:  C M Brennan; J A Steitz
Journal:  Cell Mol Life Sci       Date:  2001-02       Impact factor: 9.261

2.  Aurora-A interacts with Cyclin B1 and enhances its stability.

Authors:  Lili Qin; Tong Tong; Yongmei Song; Liyan Xue; Feiyue Fan; Qimin Zhan
Journal:  Cancer Lett       Date:  2008-11-22       Impact factor: 8.679

3.  Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling.

Authors:  Georg Feldmann; Anjali Mishra; Seung-Mo Hong; Savita Bisht; Christopher J Strock; Douglas W Ball; Michael Goggins; Anirban Maitra; Barry D Nelkin
Journal:  Cancer Res       Date:  2010-05-18       Impact factor: 12.701

4.  Preventing the degradation of mps1 at centrosomes is sufficient to cause centrosome reduplication in human cells.

Authors:  Christopher Kasbek; Ching-Hui Yang; Adlina Mohd Yusof; Heather M Chapman; Mark Winey; Harold A Fisk
Journal:  Mol Biol Cell       Date:  2007-09-05       Impact factor: 4.138

5.  Phosphorylated HuR shuttles in cycles.

Authors:  Hyeon Ho Kim; Myriam Gorospe
Journal:  Cell Cycle       Date:  2008-10-28       Impact factor: 4.534

Review 6.  Cdk5, the multifunctional surveyor.

Authors:  Vassiliki Lalioti; Diego Pulido; Ignacio V Sandoval
Journal:  Cell Cycle       Date:  2010-01-28       Impact factor: 4.534

7.  Cdk5 is essential for adult hippocampal neurogenesis.

Authors:  Diane C Lagace; David R Benavides; Janice W Kansy; Marina Mapelli; Paul Greengard; James A Bibb; Amelia J Eisch
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-18       Impact factor: 11.205

8.  Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons.

Authors:  Jie Zhang; Samantha A Cicero; Li Wang; Rita R Romito-Digiacomo; Yan Yang; Karl Herrup
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-12       Impact factor: 11.205

9.  Functional dynamics of Polo-like kinase 1 at the centrosome.

Authors:  Kazuhiro Kishi; Marcel A T M van Vugt; Ken-ichi Okamoto; Yasunori Hayashi; Michael B Yaffe
Journal:  Mol Cell Biol       Date:  2009-03-23       Impact factor: 4.272

10.  Cdk5 promotes synaptogenesis by regulating the subcellular distribution of the MAGUK family member CASK.

Authors:  Benjamin Adam Samuels; Yi-Ping Hsueh; Tianzhi Shu; Haoya Liang; Huang-Chun Tseng; Chen-Jei Hong; Susan C Su; Janet Volker; Rachael L Neve; David T Yue; Li-Huei Tsai
Journal:  Neuron       Date:  2007-12-06       Impact factor: 17.173

View more
  32 in total

Review 1.  Posttranslational control of HuR function.

Authors:  Ioannis Grammatikakis; Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-06-16       Impact factor: 9.957

2.  The RNA-Binding Protein ELAVL1 Regulates GnRH Receptor Expression and the Response to GnRH.

Authors:  Tomohiro Terasaka; Taeshin Kim; Hiral Dave; Bhakti Gangapurkar; Dequina A Nicholas; Oscar Muñoz; Eri Terasaka; Danmei Li; Mark A Lawson
Journal:  Endocrinology       Date:  2019-08-01       Impact factor: 4.736

3.  RNA-Binding Protein Musashi1 Is a Central Regulator of Adhesion Pathways in Glioblastoma.

Authors:  Philip J Uren; Dat T Vo; Patricia Rosa de Araujo; Rebecca Pötschke; Suzanne C Burns; Emad Bahrami-Samani; Mei Qiao; Raquel de Sousa Abreu; Helder I Nakaya; Bruna R Correa; Caspar Kühnöl; Jernej Ule; Jennifer L Martindale; Kotb Abdelmohsen; Myriam Gorospe; Andrew D Smith; Luiz O F Penalva
Journal:  Mol Cell Biol       Date:  2015-06-22       Impact factor: 4.272

4.  Hu antigen R (HuR) is a positive regulator of the RNA-binding proteins TDP-43 and FUS/TLS: implications for amyotrophic lateral sclerosis.

Authors:  Liang Lu; Lei Zheng; Ying Si; Wenyi Luo; Gwendal Dujardin; Thaddaeus Kwan; Nicholas R Potochick; Sunnie R Thompson; David A Schneider; Peter H King
Journal:  J Biol Chem       Date:  2014-09-19       Impact factor: 5.157

5.  Cyclin-dependent kinase activity is required for type I interferon production.

Authors:  Oya Cingöz; Stephen P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-05       Impact factor: 11.205

Review 6.  N (6)-Methyladenosine (m(6)A) Methylation in mRNA with A Dynamic and Reversible Epigenetic Modification.

Authors:  Ruifan Wu; Denghu Jiang; Yizhen Wang; Xinxia Wang
Journal:  Mol Biotechnol       Date:  2016-07       Impact factor: 2.695

7.  Hu antigen R (HuR) multimerization contributes to glioma disease progression.

Authors:  Natalia Filippova; Xiuhua Yang; Subramaniam Ananthan; Anastasia Sorochinsky; James R Hackney; Zachery Gentry; Sejong Bae; Peter King; L Burt Nabors
Journal:  J Biol Chem       Date:  2017-08-08       Impact factor: 5.157

8.  Anti-cancer effects of the HuR inhibitor, MS-444, in malignant glioma cells.

Authors:  Jiping Wang; Anita B Hjelmeland; L Burt Nabors; Peter H King
Journal:  Cancer Biol Ther       Date:  2019-04-16       Impact factor: 4.742

9.  Crystallization and preliminary X-ray diffraction of the RNA demethylase ALKBH5.

Authors:  Bin Zhou; Zhifu Han
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-10-17

10.  p39, the primary activator for cyclin-dependent kinase 5 (Cdk5) in oligodendroglia, is essential for oligodendroglia differentiation and myelin repair.

Authors:  Andrew N Bankston; Wenqi Li; Hui Zhang; Li Ku; Guanglu Liu; Filomena Papa; Lixia Zhao; James A Bibb; Franca Cambi; Seema K Tiwari-Woodruff; Yue Feng
Journal:  J Biol Chem       Date:  2013-05-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.